Kiniksa Pharmaceuticals International, plc Accrued Liabilities, Current
Kiniksa Pharmaceuticals International, plc (KNSA) had Accrued Liabilities, Current of $32.77 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-04-28
- 2026-03-31: Accrued Liabilities, Current $32.77M.
- 2025-12-31: Accrued Liabilities, Current $42.02M.
- 2025-09-30: Accrued Liabilities, Current $30.94M.
- 2025-06-30: Accrued Liabilities, Current $35.96M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $32.77M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $42.02M 10-Q · filed 2026-04-28 | |
| 2025-09-30 | $30.94M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $35.96M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $22.13M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $32.35M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $40.38M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $33.37M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $44.72M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $27.73M 10-K · filed 2025-02-25 | $44.67M 10-K · filed 2024-02-28 |
| 2023-09-30 | $41.15M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $35.32M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $20.89M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $30.11M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $30.87M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $34.50M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $38.89M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $38.03M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $28.53M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $31.06M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $30.32M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $29.20M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $19.48M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $16.50M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $13.38M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $20.41M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $19.36M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $19.18M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $15.62M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $16.42M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $13.35M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $12.58M 10-Q · filed 2018-08-06 | |
| 2017-12-31 | $6.21M 10-K · filed 2019-03-12 |